Senzime (Nasdaq Stockholm: SEZI) (OTCQX: SNZZF), a provider of perioperative patient monitoring solutions, announced on Monday that it has launched its advanced TetraGraph system for quantitative train-of-four (TOF) monitoring at ANESTHESIOLOGY 2024.

Featuring TetraGraph Adaptive Intelligence, a smart algorithm suite, the device enables real-time, precision-based neuromuscular assessments and seamless automated workflows across the perioperative process.

The next-generation TetraGraph incorporates an intuitive Level-of-Block Gauge for simplified TOF monitoring, aligning with updated clinical guidelines, and a cutting-edge EMG algorithm delivering 4x higher resolution. This enhanced functionality aims to address residual neuromuscular block (rNMB) complications, which impact many surgical patients, improving patient safety and clinical outcomes.

With sustainable, upgradable software, the new TetraGraph is designed for long-term use, adapting to evolving healthcare demands. US shipments will commence in Q4 2024, available on a first-come, first-serve basis.

With solutions in over 30 countries, Senzime continues to advance patient safety and recovery worldwide.